A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.
about
Pegylated liposomal doxorubicin in the management of ovarian cancerPegylated liposomal doxorubicin in ovarian cancer.Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment.Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative.Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect.
P2860
A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A phase I dose-finding study o ...... paclitaxel in ovarian cancer.
@ast
A phase I dose-finding study o ...... paclitaxel in ovarian cancer.
@en
type
label
A phase I dose-finding study o ...... paclitaxel in ovarian cancer.
@ast
A phase I dose-finding study o ...... paclitaxel in ovarian cancer.
@en
prefLabel
A phase I dose-finding study o ...... paclitaxel in ovarian cancer.
@ast
A phase I dose-finding study o ...... paclitaxel in ovarian cancer.
@en
P2093
P2860
P356
P1476
A phase I dose-finding study o ...... paclitaxel in ovarian cancer.
@en
P2093
S R D Johnston
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600250
P407
P577
2002-05-01T00:00:00Z